Introduction
Microtubule interacting agents (also called tubulin binding agents or spindle poisons) such as vinca alkaloids and taxanes, comprise an important class of antineoplastic agents that act by interfering with tubulin dynamics during mitosis (for review see Jordan and Wilson, 2004) . Despite the efficacy of these agents toward both solid and hematological cancers, drug resistance to tubulin binding agents remains a serious clinical problem.
The different classes of microtubule-interacting agents share an important number of properties. They are natural products or semisynthetic compounds that bind to various sites on the beta-tubulin subunit of the microtubules. Although tubulin binders act on microtubules throughout the entire cell cycle, cells are particularly vulnerable to this class of agents during the metaphase to anaphase transition where a functional mitotic spindle is absolutely required for the proper positioning, separation and migration of the mitotic chromosomes. Tubulin binders are able to induce at least three different types of cell cycle checkpoints: the prophase checkpoint that delays chromosome condensation and metaphase entry, the mitotic spindle assembly/stability checkpoint which delays the metaphase to anaphase transition, and a p53-and Rbdependent G1 tetraploidy checkpoint that arrests polyploid cells that have exited mitosis without cytokinesis (Scolnick and Halazonetis, 2000; Trielli et al., 1996; Meraldi et al., 2004) .
One of the most widely reported mechanisms of resistance to tubulin binders is associated with overexpression of different ABC transporters such as P-glycoprotein/Mdr1 (ABCB1) and different MRP (ABCC) family members (for review, see Gottesman et al., 2002) . Drug resistance has also been associated with microtubule-associated alterations such as This article has not been copyedited and formatted. The final version may differ from this version. Mol 13995 5 differential expression and/or mutations of beta-tubulin isoforms or of microtubule-binding agents such as MAP4 (for reviews, see Drukman and Kavallaris, 2002; Orr et al., 2003) . In contrast, the contribution of the different cell cycle checkpoints remains unclear since loss of these checkpoints has been reported to provide either resistance (Wahl et al., 1996; Kasai et al., 2002) or increased sensitivity to microtubule inhibitors (Trielli et al., 1996, Scolnick and Halazonetis, 2000) .
Gene expression analysis of human lung carcinoma cells showed that taxol influenced the expression of several cell cycle regulators. In particular, after 24 h drug treatment, the cyclin-dependent kinase inhibitor p21
waf1/cip1/sdi1 (CDKN1A) was upregulated as was another CDK1
modulator, 14-3-3sigma. In contrast, CDK1 (also known as cdc2 or p34 cdc2 ) and topoisomerase IIalpha were down-regulated (Chen et al., 2003) . Similar findings were reported when the effect of taxol was studied in vivo on ovarian carcinoma xenografts. Interestingly, topoisomerase IIalpha was consistently downregulated whereas p21 was upregulated in the taxol-responsive tumors (Bani et al., 2004) . Proteome analysis of vinca alkaloid-sensitive and resistant leukemia cells identified cell cycle regulators altered in both the response and in the resistance to vinca alkaloids (Verrills et al., 2003) . These included 14-3-3epsilon, a protein reported to modulate the cellular effects of both Cdc25C
phosphatase (Kumagai et al., 1998) and topoisomerase IIalpha (Kurz et al., 2000) . It is notable, that most of these genes are known to play important roles in maintaining G2 arrest in response to under-replicated or damaged DNA (Chan et al., 2000; Larsen et al., 2003) . We speculated that the repression of proteins needed for the G2 to M transition could be a distinct mechanism of maintaining G2 arrest and thus to prevent cells from entering mitosis where microtubule interacting agents are most cytotoxic.
This article has not been copyedited and formatted. The final version may differ from this version. days followed by incubation in drug-free media for at least one week but no more than four weeks. This dose of vincristine is non-toxic to the resistant cell lines but lethal to the parental ones. All cell lines were grown in RPMI 1640 medium supplemented with 10 % fetal bovine serum, 2 mM L-glutamine, penicillin (100 units/ml) and streptomycin (100 µg/ml) at 37 °C in a 5 % CO 2 /95 % air atmosphere.
The DC-3F fibrosarcoma cell line, its 9-hydroxyellipticine-selected subline DC-3F/9-0H-E and DC-3F/9-0H-E cells transfected with human Exponentially growing leukemia cells were exposed to different drug concentrations for 1 h followed by post-incubation for an additional 72 h in drug-free media. After postincubation, cells were counted with a This article has not been copyedited and formatted. The final version may differ from this version. Coulter counter and the growth inhibition was determined as described earlier (Skladanowski et al., 1996) . Values are given as the mean of three independent experiments, each done in duplicate.
Survival of the DC-3F parental and ellipticine-resistant fibrosarcoma cell lines was determined after 24 h drug-exposure followed by a colony formation assay as described earlier (Dereuddre et al., 1997) . Mol 13995 12 (Zeiss, Germany) and all data acquisition and image analysis were carried out by a LSM510 laser confocal scanning system (Zeiss).
Decatenation assay. Nuclei were isolated from exponentially growing cells as described above, and the nuclei extracted with 0.35 M NaCl for 30 min at 4 °C (Lelievre et al., 1995) . The nuclei were centrifuged at 11,000 rpm, the supernatants were collected and were frozen immediately after. Nuclear extracts were stored at -80 °C and analyzed within 4 days. For decatenation assays, the reaction mixture contained 50 mM Tris-HCl, pH 7.5, 0.5 mM EDTA, 100 mM KCl, 0.5 mM dithiothreitol, 10 mM MgCl 2 , 1 mM ATP, and 200 ng of kinetoplast DNA as previously described (Escargueil et al., 2001) . The reaction was initiated by the addition of different concentrations of nuclear extract and was allowed to proceed at 37 °C for the indicated times. Reactions were stopped by addition of 1 % SDS, 0.5 % bromophenol blue and 30 % glycerol. The samples were subjected to electrophoresis in 1.2 % agarose gels at 5 V/cm for 6 h in Tris/borate/EDTA buffer, pH 8.3. Similarly, the fraction of cells in the S phase of the cell cycle was comparable between parental and vincristine-resistant cells with 44.9 % ± 3.2 and 44.8 % ± 3.8 for HL-60 and HL-60/Vinc, respectively, and 49.5 % ± 4.7 and 46.7 % ± 5.7 for CEM and CEM/VCR1000, respectively (Fig .   1A ).
In contrast, the percentage of cells in the G2/M phase of the cell cycle was enhanced in both vincristine-resistant cell lines with 9.0 % ± 1.2 compared to 11.3 % ± 1.2 for HL-60 and HL-60/Vinc, respectively, and 8.3 % ± 0.7 versus 11.9 % ± 1.2 for CEM and CEM/VCR1000, respectively. To establish if the increased G2/M fraction was due to an increased number of mitotic cells, the mitotic index (that principally represents metaphase cells but does not include prophase cells) was determined (Fig. 1B) . Unexpectedly, the mitotic indices of both resistant (Fig. 4) . The proteins examined included p34 cdc2 , the catalytic subunit of CDK1, the cyclin kinase inhibitor p21 cip1/waf1/sdi1 and DNA topoisomerase IIalpha. In addition, we determined the expression of 14-3-3epsilon and 14-3-3sigma, that are able to inhibit the activities of topoisomerase IIalpha and the Cdc25C protein phosphatase, respectively. The results show no clear differences for the expression of CdK1, p21 or the two 14-3-3 proteins (Fig. 4) . In addition, the relative distribution between the fast- accompanied by differences in the catalytic activity (Fig. 6 ). The amount of nuclear extracts needed to decatenate 50% of the kinetoplast DNA This article has not been copyedited and formatted. The final version may differ from this version. (Fig. 6A ). The differences in catalytic activity were further confirmed by kinetic analysis that revealed that extracts from parental cells are 3-4 fold more active than extracts from vincristine-resistant cells (Fig. 6B) . Thus, the downregulation of topoisomerase IIalpha in vincristine-resistant cells was accompanied by decreased catalytic activity.
Vincristine-resistant cells are cross-resistant to topoisomerase II inhibitors. The cytotoxic activity of different topoisomerase II inhibitors
was determined in order to establish if the reduced levels of topoisomerase IIalpha also influenced the sensitivity to topoisomerase II inhibitors. Since most topoisomerase II inhibitors are recognized by the P-glycoprotein, we selected topoisomerase II inhibitors that are either poor substrates for the P-glycoprotein (amsacrine, mitoxantrone) or, in the case of Symadex (C-1311), not recognized at all (Skladanowski et al., 1996) . The results showed that vincristine-resistant cells were 4-to 20-fold cross-resistant to the tested topoisomerase II inhibitors compared to the parental cells (Table 1) . Interestingly, the vincristine-resistant cells were also cross-resistant to ICRF-187, a topoisomerase II inhibitor that stabilizes non-covalent, rather than covalent complexes between DNA and topoisomerase II (Roca et al., 1994) . Therefore, down-regulation of topoisomerase IIalpha in the vincristine-selected cells was accompanied by cross-resistance to different functional classes of topoisomerase II inhibitors.
Topoisomerase IIalpha modulates the cell cycle distribution in

G2 and M. Our studies revealed that vincristine-selection of human leukemia cells was accompanied by altered cell cycle progression in G2
This article has not been copyedited and formatted. The final version may differ from this version. The results showed that ellipticine resistance was accompanied by an increased fraction of cells in G2/M (Fig. 7A ) and a reduced mitotic index ( To establish if topoisomerase II protein levels directly influence the cellular sensitivity to microtubule interacting agents, the isogenic eliipticine-resistant cells were exposed to nocodazole for 24 h followed by postincubation in drug-free media and the cytotoxicity was determined by colony formation (Fig. 9) . The results show that the expression of topoisomerase IIalpha plays an important role in the sensitivity to nocodazole with IC 50 values corresponding to 0.09 µg/ml for the topoisomerase IIalpha transfectants compared to 0.30 µg/ml for the ellipticine-resistant parental cells. These changes are statistically different (p<0.001). In contrast, no significant differences were observed between the topoisomerase IIbeta transfectants and the ellipticineresistant parental cells.
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Discussion
Cell cycle arrest in the G2 phase of the cell cycle can be triggered by a wide range of different stress stimuli known to influence DNA and nuclear functions. More recently, it has been reported that microtubule interacting agents can also influence the expression of several important regulators of the G2 to M transition such as CDK1 kinase and topoisomerase IIalpha that are downregulated, and the cyclin-dependent kinase inhibitor p21 and 14-3-3 proteins that are upregulated (Chen et al., 2003; Verrills et al., 2003; Bani et al., 2004) . These findings suggest that tubulin interacting-agents might be able to influence the G2 to M progression thereby retaining cells in a part of the cell cycle where they are less sensitive to the cytotoxic effects of such agents.
To explore this hypothesis, we characterized the cell cycle distribution Western blot analysis was performed to compare cellular levels of major G2/M regulators in parental and vincristine-resistant cells. Since the same proteins often are implicated both in the response and in the resistance to cytotoxic agents, we focused on genes previously shown to be influenced by exposure to taxol, epothilone B or vincristine (Chen et al., 2003; Verrills et al., 2003; Bani et al., 2004) . Unexpectedly, no detectable alterations were observed for CDK1, p21, 14-3-3sigma or 14-
3-3epsilon. In clear contrast, topoisomerase IIalpha was downregulated
This article has not been copyedited and formatted. The final version may differ from this version. Mol 13995 22 to about one third of the initial levels in both vincristine-resistant cell lines which was accompanied by a 3-4 fold decrease in the catalytic activity and cross-resistance to topoisomerase II inhibitors.
Topoisomerase IIalpha is a dynamic molecule that can be either associated with DNA or be present in the nucleoplasm (Tavormina et al., 2002) . We therefore determined the association of topoisomerase IIalpha with mitotic chromosomes in parental and vincristine-resistant cells by immunoblotting followed by image analysis. The results showed that the association of topoisomerase IIalpha with mitotic chromosomes was reduced at least 7-fold in the vincristine-resistant cells compared to the sensitive parental cells. These findings suggested that the altered cell cycle progression of vincristine-selected cells might, at least in part, be directly related to the downregulation of topoisomerase IIalpha.
Topoisomerase IIalpha is already known to play several essential roles during late G2 and early mitosis (for reviews, see Larsen et al., 2003; Swedlow and Hirano, 2003) . First, topoisomerase II is required for premitotic chromosome individualization, the process by which different chromosomes become untangled and converted into individual units (Gimenez-Abian et al., 2000) . The protein also plays a direct role in early chromosome condensation by a so far poorly understood mechanism that, at least in part, seems to rely on protein-protein and DNA-protein interactions (Adachi et al., 1991) . In addition, topoisomerase IIalpha is needed for recruitment of CDK1 to the chromatin of mitotic chromosomes (Escargueil et al., 2001 ) and thus for mitotic To further explore the influence of topoisomerase II on the sensitivity to microtubule-interacting agents, the different ellipticine-resistant cell lines were exposed to nocodazole for 24 h followed by post-incubation in drug-free media. The results reveal that topoisomerase IIalpha, but not topoisomerase IIbeta, directly influence the cellular sensitivity to microtubule-interacting agents.
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Therefore, the downregulation of topoisomerase IIalpha would qualify as an adaptation process rather than a checkpoint mechanism. Although long-lasting, this is a dynamic response, since no differences in topoisomerase II levels and activities were observed when more than 4 weeks had expired since the selection process ended. Another major difference between our findings and classical G2 and prophase checkpoints is that the modified cell cycle progression in G2 and early M can be observed even for untreated cells. The down-regulation of topoisomerase IIalpha could be due to downregulation of its promoter. The topoisomerase IIalpha promoter is regulated in a cell-cycle dependent manner, with maximal activity at the G2/M interphase (Woessner et al., 1991) and contains five inverted CCAAT boxes (ICBs), two GC boxes and an ATF site (Hochhauser et al., 1992) . It has previously been reported that vinblastine is able to downregulate the topoisomerase IIalpha promoter, at least in p53-proficient cells (Joshi et al., 2003) . This is likely also to be the case for p53-deficient cells, since microtubule inhibitors may lead to DNA damage as a result of abnormal mitosis producing chromosomal breakage and other chromosomal damage (Chen et al., 2003) .
In conclusion, we here report that downregulation of topoisomerase This article has not been copyedited and formatted. The final version may differ from this version. 
